1. Home
  2. LIMN vs EU Comparison

LIMN vs EU Comparison

Compare LIMN & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIMN
  • EU
  • Stock Information
  • Founded
  • LIMN 2018
  • EU 2009
  • Country
  • LIMN United States
  • EU United States
  • Employees
  • LIMN N/A
  • EU N/A
  • Industry
  • LIMN
  • EU Other Metals and Minerals
  • Sector
  • LIMN
  • EU Basic Materials
  • Exchange
  • LIMN NYSE
  • EU Nasdaq
  • Market Cap
  • LIMN 623.8M
  • EU 538.3M
  • IPO Year
  • LIMN N/A
  • EU N/A
  • Fundamental
  • Price
  • LIMN $5.93
  • EU $2.54
  • Analyst Decision
  • LIMN
  • EU Strong Buy
  • Analyst Count
  • LIMN 0
  • EU 1
  • Target Price
  • LIMN N/A
  • EU $2.75
  • AVG Volume (30 Days)
  • LIMN 987.0K
  • EU 2.5M
  • Earning Date
  • LIMN 01-01-0001
  • EU 08-13-2025
  • Dividend Yield
  • LIMN N/A
  • EU N/A
  • EPS Growth
  • LIMN N/A
  • EU N/A
  • EPS
  • LIMN N/A
  • EU N/A
  • Revenue
  • LIMN N/A
  • EU $46,179,000.00
  • Revenue This Year
  • LIMN N/A
  • EU $33.42
  • Revenue Next Year
  • LIMN N/A
  • EU $104.87
  • P/E Ratio
  • LIMN N/A
  • EU N/A
  • Revenue Growth
  • LIMN N/A
  • EU N/A
  • 52 Week Low
  • LIMN $4.40
  • EU $1.01
  • 52 Week High
  • LIMN $33.66
  • EU $4.44
  • Technical
  • Relative Strength Index (RSI)
  • LIMN N/A
  • EU 41.28
  • Support Level
  • LIMN N/A
  • EU $2.91
  • Resistance Level
  • LIMN N/A
  • EU $3.20
  • Average True Range (ATR)
  • LIMN 0.00
  • EU 0.18
  • MACD
  • LIMN 0.00
  • EU -0.07
  • Stochastic Oscillator
  • LIMN 0.00
  • EU 17.50

About LIMN LIMINATUS PHARMA INC

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.

Share on Social Networks: